Italia markets open in 5 hours 27 minutes

DENTSPLY SIRONA Inc. (XRAY)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
34,13+0,16 (+0,47%)
Alla chiusura: 04:00PM EDT
34,19 +0,06 (+0,18%)
Dopo ore: 06:50PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente33,97
Aperto33,96
Denaro32,95 x 800
Lettera34,74 x 800
Min-Max giorno33,83 - 34,32
Intervallo di 52 settimane26,48 - 43,24
Volume1.776.810
Media Volume1.465.741
Capitalizzazione7,226B
Beta (5 anni mensile)0,98
Rapporto PE (ttm)N/D
EPS (ttm)-4,76
Prossima data utili13 nov 2023 - 17 nov 2023
Rendimento e dividendo (futuro)0,56 (1,62%)
Data ex dividendo28 set 2023
Stima target 1A44,70
  • GlobeNewswire

    Dentsply Sirona to Host Investor Day on November 9, 2023

    CHARLOTTE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host its Investor Day in Charlotte, North Carolina, on November 9, 2023. The event will begin at 8:30 AM ET. Due to space limitations, in-person attendance requires advanced registration. Those interested in attending the event in-person can contact InvestorRelations@dentsplysirona.com for more information. Investors and other interest

  • GlobeNewswire

    Dentsply Sirona to Participate in the Baird 2023 Global Healthcare Conference

    CHARLOTTE, N.C., Aug. 18, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2023 Global Healthcare Conference. Management is scheduled to participate in a fireside chat discussion on September 12, 2023, at 9:05 am ET. Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona websit

  • GlobeNewswire

    Dentsply Sirona Reports Second Quarter 2023 Results

    Net sales increased 0.5% to $1,028 million, organic sales increased 2.3%GAAP net income of $86 million, GAAP earnings per share of $0.40Adjusted EBITDA margin of 17.7%, adjusted EPS of $0.51Raising midpoint of FY23 net sales by $75 million to a range of $3.98 billion to $4.02 billionRaising FY23 organic sales growth outlook to approximately 3% (previously flat to up 2%)Raising FY23 adjusted EPS outlook to a range of $1.92 to $2.02 (previously $1.85 to $2.00) CHARLOTTE, N.C., Aug. 02, 2023 (GLOBE